期刊文献+

肝胆特异性对比剂在肝脏局灶性病变鉴别诊断中的价值 被引量:4

下载PDF
导出
摘要 肝胆特异性对比剂MRI增强扫描在肝脏局灶性病变良恶性鉴别诊断中具有重要的应用价值。肝胆特异期扫描可提高局灶性病变的诊断率和肝内占位性病变的鉴别诊断水平。
出处 《中国中西医结合影像学杂志》 2014年第5期539-542,共4页 Chinese Imaging Journal of Integrated Traditional and Western Medicine
  • 相关文献

参考文献28

  • 1Burke C,Alexander Grant L, Goh V, et al. The role of hepato- cyte-specific contrast agents in hepatobiliary magnetic resonance imaging[J]. Semin Ultrasound CT MR, 2013,34 : 44-53.
  • 2Reimer P,Schneider G,Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver., properties, clinical devel- opment and applications[J]. Eur Radiol, 2004,14 : 559-578.
  • 3Purysko AS,Remer EM, Veniero JC. Focal liver lesion detection and characterization with GD-EOB-DTPA[J]. ClinRadial, 2011, 66 : 673-684.
  • 4Bollow M, Taupitz M, Hamm B, et al. Gadolinium-ethoxybenzyl- DTPA as a hepatobiliary contrast agent for use in MK cholan- giography:results of an in vivo phase-I clinical evaluation[J]. Eur Radiol, 1997,7 : 126-132.
  • 5Rohrer M, Bauer H, Mintorovitch J, et al. Comparison ofmag- netic properties of MRI contrast media solutions at different magnetic field strengths[J]. Invest Radiol, 2005,40 : 715-724.
  • 6Kim SH, Jeong WK, Kim Y, et al. Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI[J]. Clin Mol Hepatol, 2013, 19:92-96.
  • 7Pastor CM, Planchamp C, Poehon S, et al. Kinetics of gado- benate dimeglumine in isolated perfused rat liver: MR imaging e- valuation[J]. Radiology, 2003,229 : 119 -125.
  • 8Tsuboyama T, Onishi H, Kim T, et al. Hepatocellular carcino- ma : hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of slnusoidal and canal- [cular transporters and bile accumulation[J]. Radiology, 2010, 255:824-833.
  • 9Kirehin MA,Pirovano GP,Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA) :an overiew[J]. Invest Radiol, 1998,33 : 798-809.
  • 10Tanimoto A, Higuchi N,Ueno A. Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging[J]. Magn Reson Med Sei, 2012,11 : 91-97.

二级参考文献23

  • 1Schuhmann Giampieri G, Schmitt-Willieh H, Press WR, et al. Pre- clinical evaluation of Gd-EOB DTPA as a contrast agent in MR imaging of the hepatobiliary system[J]. Radiology, 1992,183 ( 1 ) 59-64.
  • 2Weimn ann H J, Schuhmann-Giampieri G, Schmitt Willich H, et al. A new lipophilic gadolini umche]ate as a tissue specific contrast medium for MR imaging[J]. Magn Reson Med, 1991 ,22(2) : 233- 237.
  • 3Hamm B,Staks T,Muhler A,et al. Phase clinical evaluation of Gd EOB DTPA as a hepatobiliary MR contrast agent: safety, pharma cnkinetics,and MR imaging[J]. Radiology, 1995,195(3) :785-792.
  • 4Reimer P,Rummeny E J, Shamsi K, et al. Phase clinical evaluation of Gd EOB DTPA: dose, safety aspects, and pulse sequence[J]. Radiology, 1996,199(1) : 177-183.
  • 5Voga TJ,Kummel S, Hammerstingl R,et ah Liver tumors: con, parison of MR imaging with Gd EOB DTPA and Gd DTPA[J]. Radiology,1996,200(1):59- 67.
  • 6Raman SS,I.cary C,Bluemke DA,et al. hnproved characterization of focal liver lesions with liver specific gadoxetic acid disodium en hanced magnetic resonance imaging: a muhicenter phase 3 clinical trial[J]. J Comput Assist Tomogr,2010,34(2):163 -172.
  • 7Zech CJ, Herrmann KA,Reiser MF,et al. MR imaging in patients with suspected liver metastases: value of liver specific contrast a gent Gd EOB-DTPA[J]. Magn Reson Med Sci, 2007,6(1) :43- 52.
  • 8Halavaara J, Breuer J, Ayuso C, et al. I.iver tumor characteriza tion:comparison between liver specific Gadoxetic Acid Disodium enhanced MRI and biphasic CT-a muhicenter trial[J]. J Comput Assist Tomogr,2006,30(3) :345- 354.
  • 9Zech C J, C-razioli I., Breuer J, et al. Diagnostic performance and de scription of morphological features of focal nodular hyperplasia in Gd EOB DTPA-enhanced liver magnetic resonance imaging: re suhs of a multicenter triat[J]. Invest Radiol,2008,43(7): 504 -511.
  • 10Quillin SP, Atilla S, Brown JJ, et al. Characterization of focal hepatic masses by dynamic contrast enhanced MR imaging:findings in 311 lesions[J]. Magn Reson Imaging, 1997,15(3) :275-285.

共引文献5

同被引文献24

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部